Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News BioVie Inc BIVI

Healthcare Biotechnology
BioVie Inc. is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders. In neurodegenerative disease, the Company’s drug candidate bezisterim (NE3107) inhibits inflammatory activation of extracellular signal-regulated kinase and the transcription factor, Nuclear factor- kB, and the... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:BIVI)

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against BioVie Inc. (BIVI) And Encourages Investors to Reach Out

Accesswire 2 days ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against BioVie Inc. (BIVI) And Encourages Stockholders to Reach Out

Accesswire 4 days ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating BioVie Inc. (BIVI) And Encourages Stockholders to Connect

Accesswire 8 days ago

BioVie Inc. (BIVI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Accesswire 11 days ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against BioVie Inc. (BIVI) and Encourages Stockholders to Learn More About the Investigation

Accesswire December 11, 2024

BioVie to Present Design of Planned Phase 2 Study of Bezisterim for the Treatment of Long COVID at the Demystifying Long COVID International Conference

GlobeNewswire November 20, 2024

BioVie's Upcoming Parkinson's Disease Clinical Trial is Fully Funded

GlobeNewswire November 4, 2024

BioVie Inc. Announces Closing of Registered Direct Offering

GlobeNewswire October 29, 2024

UPDATE -- BioVie Inc. Announces Pricing of Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

GlobeNewswire October 28, 2024
View More News ››

Opinion & Analysis (NDAQ:BIVI)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:BIVI)

Bronstein, Gewirtz & Grossman, LLC Announces an Investigatio

Breaking News: $BIVI Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against BioVie Inc. (BIVI) and Encourages...
whytestocks - December 11, 2024

Still holding up

BIVI has dug itself out of the recent hole so it just shows that patient is needed for returns
Tradinghands - October 24, 2024

75% pop!

This started moving on Friday now huge volume with a 75% spike! Friday was the time to buy
Tradinghands - October 21, 2024

Quantum BioPharma Files $700M Federal Lawsuit Against CIBC W

News; $BIVI Quantum BioPharma Files $700M Federal Lawsuit Against CIBC World Markets, RBC Dominion Securities and Others, for Possible...
whytestocks - October 21, 2024

BUY BUY BUY BUY BUY

Acuitas fnb takes 44% OWNERSHIP 
Nibinator - July 22, 2024

Genetic Technologies and BioVie Interviews to Air on the Red

BREAKING NEWS: $BIVI Genetic Technologies and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg...
whytestocks - April 12, 2024
View more Bullboard ››

Forge Resources Corp.

Forge Resources Corp.

Forge Resources Corp. is a junior exploration company. The Company is engaged in the business of the exploration and ...
View More »